At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
Whether it’s running a marathon or helping businesses thrive in applying new technology innovations at scale, we understand what it takes to keep pushing the limits of what’s possible.
Through studies, reports and points of view, we deliver forward-looking, practical insights on key issues at the intersection of business and tech.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
Dr. Niraj Vyas
Associate Vice President and Head, TCS ADD Analytics and Insights
You have these already downloaded
We have sent you a copy of the report to your email again.
Next-gen technologies can impact the risk-based monitoring in clinical trials.
Considering the growing demands to get better and affordable treatment options, there needs to be a fundamental shift in drug development and specifically the clinical trials oversight processes to mitigate risks and reduce failures. The International Council for Harmonization (ICH) E6 R2 addendum has now provided guidelines for adaptation of risk-based approach to trial conduct and monitoring to implement mitigation strategies and key risk indicators for potential risks which might derail the conduct of the trial. However, with the changing landscape of drug development which includes novel therapies such as gene therapy, decentralized trials, wearable technologies, eSource, electronic health record interoperability, and implementation of AI ML algorithms, the future of risk-based approach towards managing clinical trials is going to be very different from what we see now.
TCS ADD™ Medical Monitoring: Revolutionize Subject Data Analysis
Artificial Intelligence – A Game Changer in Unifying Clinical Data
TCS ADD™ Webinar: Shaping the Future of AI-driven SDTM Harmonization
Automating Third Party Data Transfer Through Digitized Electronic DTA